Peer-reviewed articleOpen access

Correction: Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post‑Hoc Analysis.

Otto ME iD, van der Heijden KV iD, Schoones JW iD, van Esdonk MJ iD, Borghans LGJM iD, Jacobs GE, van Hasselt JGC iD

Clinical pharmacokineticsMar 1, 2025License: open accessNetherlands0 citationsDOI: 10.1007/s40262-025-01487-3

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Psilocybin

View paper Full text (PDF)

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticlePsilocybin

Association of Psilocybin Use in Adolescents with Major Depressive Episode

Shah K, Trivedi C, Kamrai D +2

Europe PMC2022

ArticlePsilocybin

Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain.

Spain A, Howarth C, Khrapitchev AA +3

Europe PMC2015

ArticlePsilocybin

Australia to prescribe MDMA and psilocybin for PTSD and depression in world first.

Haridy R

Europe PMC2023